Competidores
Simbolo bursátil | Precio | Pronóstico 1A | Pronóstico 2A | Cap. Mercado | Div Yld | Tasa de crecimiento |
---|---|---|---|---|---|---|
NYSE:LLY
Eli Lilly and
|
770.00 | -48.73% | -27.69% | 693,312.15 | 0.68% | 2.63% |
NYSE:ABBV
AbbVie
|
166.42 | -23.06% | -12.89% | 293,875.72 | 3.73% | 7.03% |
LSE:AZN
AstraZeneca PLC
|
121.10 | 18.89% | 41.61% | 187,733.46 | 2.01% | 15.98% |
SWX:ROG
Roche Holding
|
237.10 | 25.34% | 40.63% | 191,277.25 | 4.05% | 0.43% |
SWX:NOVN
Novartis
|
93.37 | 8.15% | 21.52% | 190,512.74 | 3.53% | 4.67% |
NasdaqGS:AMGN
Amgen
|
312.47 | -12.26% | -3.47% | 167,619.75 | 2.88% | 5.31% |
NYSE:PFE
Pfizer
|
28.64 | 8.42% | 38.65% | 162,291.22 | 5.87% | -9.31% |
ENXTPA:SAN
Sanofi
|
89.17 | 19.33% | 38.3% | 111,472.92 | 4.22% | 8.19% |
NYSE:BMY
Bristol-Myers Squibb
|
44.03 | 61.74% | 72.08% | 89,253.22 | 5.45% | 13.54% |
ENXTBR:UCB
UCB
|
124.70 | -40.45% | -12.92% | 23,661.9 | 1.09% | -2.55% |
NYSE:TEVA
Teva Pharmaceutical Industries
|
16.29 | -46.21% | -42.74% | 18,450.72 | 0% | -2.6% |
TSE:4503
Astellas Pharma
|
1487.00 | 0% | 0% | 2,666,170.81 | 4.98% | 0% |
TSE:4523
Eisai
|
6779.00 | 0% | 0% | 1,968,631.52 | 2.36% | 0% |
BIT:REC
Recordati Industria Chimica e Farmaceutica
S.p.A. |
51.20 | 18.28% | 30.99% | 10,363.08 | 2.34% | 10.99% |
ENXTPA:IPN
Ipsen
|
120.80 | -14.58% | -6.56% | 9,878.9 | 0.99% | 9.14% |
NasdaqGS:ITCI
Intra-Cellular Therapies
|
65.00 | 0% | 0% | 6,858.14 | 0% | 0% |
BME:GRF
Grifols
|
9.89 | 239.26% | 342.33% | 5,853.27 | 0% | -19.25% |
HLSE:ORNBV
Orion Oyj
|
37.69 | 22.61% | 65.62% | 5,117.58 | 4.3% | -0.43% |
NasdaqGS:ALKS
Alkermes
|
24.15 | 179.13% | 204.47% | 4,105.31 | 0% | 18.74% |
TSE:4506
Sumitomo Pharma
|
464.00 | 0% | 0% | 396,895 | 0% | 17.88% |